T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.88% |
| 2 | Healthcare | 16.96% |
| 3 | Financials | 13.79% |
| 4 | Consumer Discretionary | 13.57% |
| 5 | Industrials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VISN
1726
Vistance Networks Inc
VISN
$2.62B
| $1.32M | ﹤0.01% |
84,067
+7,882
| +10% | +$160K |
|
|
SYRS
1727
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $1.32M | ﹤0.01% |
14,243
-1,485
| -9% | -$103K |
|
1728
Planet Fitness
PLNT
$3.71B
| $1.31M | ﹤0.01% |
18,085
+3,302
| +22% | +$249K |
|
1729
Lakeland Financial Corp
LKFN
$1.56B
| $1.3M | ﹤0.01% |
27,862
+63
| +0.2% | +$2.94K |
|
1730
NBT Bancorp
NBTB
$2.79B
| $1.3M | ﹤0.01% |
34,778
+102
| +0.3% | +$3.79K |
|
1731
Brixmor Property Group
BRX
$9.21B
| $1.3M | ﹤0.01% |
72,745
+43
| +0.1% | +$773 |
|
1732
SM Energy
SM
$7.71B
| $1.3M | ﹤0.01% |
103,492
+10,794
| +12% | +$157K |
|
1733
Park National Corp
PRK
$3.75B
| $1.29M | ﹤0.01% |
13,025
-1,976
| -13% | -$192K |
|
|
QUOT
1734
DELISTED
Quotient Technology Inc
QUOT
| $1.29M | ﹤0.01% |
120,214
+6,147
| +5% | +$62.3K |
|
1735
Enviri
NVRI
$564M
| $1.29M | ﹤0.01% |
47,020
+163
| +0.3% | +$3.98K |
|
|
ARNA
1736
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $1.29M | ﹤0.01% |
22,008
+127
| +0.6% | +$6.56K |
|
1737
ATI
ATI
$30.9B
| $1.28M | ﹤0.01% |
51,001
+262
| +0.5% | +$6.39K |
|
|
BID
1738
DELISTED
Sotheby's
BID
| $1.28M | ﹤0.01% |
22,079
-390,095
| -95% | -$16.3M |
|
1739
Agree Realty
ADC
$9.34B
| $1.28M | ﹤0.01% |
19,996
+158
| +0.8% | +$10.6K |
|
1740
Horace Mann Educators
HMN
$2.1B
| $1.28M | ﹤0.01% |
31,790
+104
| +0.3% | +$4.08K |
|
|
SAVE
1741
DELISTED
Spirit Airlines, Inc.
SAVE
| $1.28M | ﹤0.01% |
26,752
+1,857
| +7% | +$94.6K |
|
|
UMPQ
1742
DELISTED
Umpqua Holdings Corp
UMPQ
| $1.27M | ﹤0.01% |
76,754
+303
| +0.4% | +$5.12K |
|
1743
Dine Brands
DIN
$440M
| $1.27M | ﹤0.01% |
13,317
-2,259
| -15% | -$206K |
|
|
HTD
1744
John Hancock Tax-Advantaged Dividend Income Fund
HTD
$904M
| $1.27M | ﹤0.01% |
50,000
| – | – |
|
1745
KLX Energy Services
KLXE
$36M
| $1.27M | ﹤0.01% |
12,412
+6
| +0% | +$729 |
|
|
TGNA
1746
DELISTED
TEGNA Inc
TGNA
| $1.27M | ﹤0.01% |
83,629
+580
| +0.7% | +$8.94K |
|
1747
Otter Tail
OTTR
$3.9B
| $1.27M | ﹤0.01% |
23,977
+99
| +0.4% | +$5.04K |
|
1748
KB Home
KBH
$3.45B
| $1.26M | ﹤0.01% |
49,138
+137
| +0.3% | +$3.53K |
|
1749
Inspire Medical Systems
INSP
$1.68B
| $1.26M | ﹤0.01% |
20,775
-684,816
| -97% | -$36.9M |
|
1750
Olin
OLN
$2.17B
| $1.26M | ﹤0.01% |
57,492
+61
| +0.1% | +$1.36K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.